Bringing the fundamentals into focus…
Back to Amneal Pharmaceuticals, Inc.
How Amneal Pharmaceuticals, Inc. stacks up
AMRX · against 1,335 other Healthcare companies
Profitability
72/ 100
Above the middle of the pack.
Ranked #369 of 1,336 · scores higher than 72% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 70–79, including AMRX · Click a bar to see the companies
Why profitability scores 72?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on invested capital, operating margin and return on assets, which are stronger than most Healthcare peers.
- a higher return on assets: stronger than 68% of peers. Return on assets: 4.2% vs peer median 1.7%
- a wider operating margin: stronger than 70% of peers. Operating margin: 14.6% vs peer median 7.1%
- a higher return on invested capital: stronger than 78% of peers. Return on invested capital: 14.5% vs peer median 4.7%
Metric by metric
Position: dot = AMRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AMRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | 14.5% | 4.7% | 78% | 33% | |
| Operating marginHigher is better · 1,251 reported | 14.6% | 7.1% | 70% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 4.2% | 1.7% | 68% | 33% | |
| Return on equityHigher is better · 1,252 reported | 613.0% | 3.2% | 100% | Context only | |
| Gross marginHigher is better · 1,394 reported | 39.8% | 45.9% | 44% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around AMRX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 369 | 7.2B CNY (≈$1.0B) | 72 | 61 | |
| 369 | 4.2B TWD (≈$129M) | 72 | 57 | |
| 369 | 3.4B SAR (≈$909M) | 72 | 62 | |
| 369 | 3.1B HKD (≈$396M) | 72 | 61 | |
| 369 | 7.0B USD | 72 | 57 | |
| 369 | 6.1B CHF (≈$7.0B) | 72 | 58 | |
| 369 | 748M USD | 72 | 62 | |
| 369 | 27.3B USD | 72 | 55 | |
| 369 | 2.0B EUR (≈$2.1B) | 72 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score